UTMD (Utah Medical Products) Cyclically Adjusted FCF per Share: $4.79 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

UTMD Utah Medical Products Inc UTMD
73 GF Score
Price $70.84
GF Value $57.89
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Utah Medical Products Cyclically Adjusted FCF per Share?

Utah Medical Products UTMD +0.41% 73 Cyclically Adjusted FCF per Share is $4.79 as of Jun. 2026. GuruFocus rates UTMD with a GF Score™ of 73/100 and a GF Value™ of $57.89 (Modestly Overvalued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Utah Medical Products's adjusted free cash flow per share for the three months ended in Jun. 2026 was $0.392. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $4.79 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Utah Medical Products's average Cyclically Adjusted FCF Growth Rate was -1.00% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 3.40% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 6.30% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 6.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Utah Medical Products was 24.00% per year. The lowest was -0.70% per year. And the median was 6.40% per year.

As of today (2026-08-27), Utah Medical Products's current stock price is $70.84. Utah Medical Products's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was $4.79. Utah Medical Products's Cyclically Adjusted Price-to-FCF of today is 14.79.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Utah Medical Products was 35.51. The lowest was 10.83. And the median was 22.48.


Utah Medical Products  (NAS:UTMD) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Utah Medical Products's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=70.84/4.79
=14.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Utah Medical Products was 35.51. The lowest was 10.83. And the median was 22.48.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Utah Medical Products Cyclically Adjusted FCF per Share Related Terms


Utah Medical Products Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Utah Medical Products's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Utah Medical Products Cyclically Adjusted FCF per Share Chart

Utah Medical Products Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.98 4.34 4.67 4.72 4.80

Utah Medical Products Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.84 4.84 4.80 4.83 4.79

UTMD vs EMBC, SMTI, PDEX: Cyclically Adjusted FCF per Share Comparison

For the Medical Instruments & Supplies subindustry, Utah Medical Products's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Utah Medical Products Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Utah Medical Products's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Utah Medical Products's Cyclically Adjusted Price-to-FCF falls into.


UTMD
73GF Score
Utah Medical Products Inc UTMD
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Utah Medical Products Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Utah Medical Products's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.392/333.9520*333.9520
=0.392

Current CPI (Jun. 2026) = 333.9520.

Utah Medical Products Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 0.855 241.428 1.183
201612 0.088 241.432 0.122
201703 1.138 243.801 1.559
201706 0.907 244.955 1.237
201709 1.209 246.819 1.636
201712 0.844 246.524 1.143
201803 0.959 249.554 1.283
201806 1.053 251.989 1.396
201809 1.212 252.439 1.603
201812 1.161 251.233 1.543
201903 -4.722 254.202 -6.203
201906 0.419 256.143 0.546
201909 1.672 256.759 2.175
201912 1.431 256.974 1.860
202003 1.402 258.115 1.814
202006 0.935 257.797 1.211
202009 1.345 260.280 1.726
202012 1.567 260.474 2.009
202103 1.511 264.877 1.905
202106 1.226 271.696 1.507
202109 1.617 274.310 1.969
202112 1.289 278.802 1.544
202203 1.312 287.504 1.524
202206 1.263 296.311 1.423
202209 1.450 296.808 1.631
202212 1.556 296.797 1.751
202303 1.890 301.836 2.091
202306 1.262 305.109 1.381
202309 1.356 307.789 1.471
202312 1.442 306.746 1.570
202403 1.452 312.332 1.553
202406 0.749 314.175 0.796
202409 1.083 315.301 1.147
202412 0.865 315.605 0.915
202503 1.293 319.799 1.350
202506 0.869 322.561 0.900
202509 1.201 324.800 1.235
202512 1.053 324.054 1.085
202603 0.935 330.213 0.946
202606 0.392 333.952 0.392

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $4.79 mean?
Utah Medical Products (UTMD) has a Cyclically Adjusted FCF per Share of $4.79 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Utah Medical Products and its competitors.
Is Utah Medical Products' Cyclically Adjusted FCF per Share too high?
Utah Medical Products' current Cyclically Adjusted FCF per Share is $4.79. Overall, Utah Medical Products has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Utah Medical Products' Cyclically Adjusted FCF per Share compare to EMBC and SMTI?
Utah Medical Products' Cyclically Adjusted FCF per Share of $4.79 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Utah Medical Products and its competitors. Utah Medical Products's current Cyclically Adjusted FCF per Share is $4.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Utah Medical Products stock overvalued right now?
Based on GuruFocus' analysis, Utah Medical Products (UTMD) is currently considered Modestly Overvalued. The stock's GF Value™ is $57.89, compared to a current price of $70.84 — trading 22.4% above its estimated fair value. The current Cyclically Adjusted FCF per Share is $4.79. Utah Medical Products' overall GF Score™ is 73/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Utah Medical Products (UTMD), the current Cyclically Adjusted FCF per Share is $4.79 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Utah Medical Products (UTMD) Overvalued in 2026?

Based on GuruFocus' analysis, Utah Medical Products stock appears to be overvalued. The current stock price of $70.84 is trading 22.4% above its estimated GF Value™ of $57.89. GuruFocus considers Utah Medical Products to be Modestly Overvalued.

Key valuation signals for UTMD:

  • Cyclically Adjusted FCF per Share: $4.79
  • GF Value™: $57.89 vs. price of $70.84 (22.4% above fair value)
  • GF Score™: 73/100 with 8 warning signs

No single metric tells the full story. See the UTMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Utah Medical Products Business Description

Other Exchanges UTM:Germany
Address 7043 South 300 West, Midvale, UT, USA, 84047
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
73GF Score

Get the complete analysis for UTMD

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$70.84
Price
$57.89
GF Value